107 related articles for article (PubMed ID: 22739193)
1. [Cloning of mouse adam10 gene promoter and construction and identification of dual luciferase reporter system].
Chen W; Chen C; Zhang HX; Cao J; Sang W; Wu QY; Zhao K; Zang Y; Zeng LY; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):740-3. PubMed ID: 22739193
[TBL] [Abstract][Full Text] [Related]
2. [Construction and identification of luciferase reporter gene containing mouse T-bet promoter].
Xu H; Zhou S
Sheng Wu Gong Cheng Xue Bao; 2014 Nov; 30(11):1733-41. PubMed ID: 25985524
[TBL] [Abstract][Full Text] [Related]
3. A novel blood-brain barrier co-culture system for drug targeting of Alzheimer's disease: establishment by using acitretin as a model drug.
Freese C; Reinhardt S; Hefner G; Unger RE; Kirkpatrick CJ; Endres K
PLoS One; 2014; 9(3):e91003. PubMed ID: 24608847
[TBL] [Abstract][Full Text] [Related]
4. [Construction and validation of a dual-luciferase reporter gene system for screening and evaluating anti-liver fibrosis drugs that inhibit transcription of the gene encoding collagen I, chain a1].
Zhang W; Dai X; Yu H; Wang L; Sun S; Li J; Zhou Y
Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):747-51. PubMed ID: 25496864
[TBL] [Abstract][Full Text] [Related]
5. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
6. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
[TBL] [Abstract][Full Text] [Related]
7. [Preliminary evaluation of promoter regions of four Schistosoma japonicum genes for expressing a luciferase reporter].
Luo R; Guo SX; Shi YJ; Cheng GF
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Jun; 25(3):246-9. PubMed ID: 24024440
[TBL] [Abstract][Full Text] [Related]
8. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
[TBL] [Abstract][Full Text] [Related]
9. ADAM10 expression and promoter haplotype in Alzheimer's disease.
Bekris LM; Lutz F; Li G; Galasko DR; Farlow MR; Quinn JF; Kaye JA; Leverenz JB; Tsuang DW; Montine TJ; Peskind ER; Yu CE
Neurobiol Aging; 2012 Sep; 33(9):2229.e1-2229.e9. PubMed ID: 22572541
[TBL] [Abstract][Full Text] [Related]
10. [Construction of kir3dl1 promoter expression vector and its activity in K562 cell line].
Gao XN; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):258-62. PubMed ID: 18426644
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the alpha-secretase ADAM10 by retinoic acid receptors and acitretin.
Tippmann F; Hundt J; Schneider A; Endres K; Fahrenholz F
FASEB J; 2009 Jun; 23(6):1643-54. PubMed ID: 19144697
[TBL] [Abstract][Full Text] [Related]
12. [Cloning of ID4 gene expression regulation promoter and subcloning of recombinant ID4 promoter luciferase reporter].
Li W; Huang Y; Yang B; Chi XH; Liu LH; Zhang F; Yan JW; Lu XC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):421-6. PubMed ID: 20416180
[TBL] [Abstract][Full Text] [Related]
13. Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease.
Reinhardt S; Schuck F; Grösgen S; Riemenschneider M; Hartmann T; Postina R; Grimm M; Endres K
FASEB J; 2014 Feb; 28(2):978-97. PubMed ID: 24165480
[TBL] [Abstract][Full Text] [Related]
14. T-cell immunoglobulin and mucin domain 2 (TIM-2) is a target of ADAM10-mediated ectodomain shedding.
Dewitz C; Möller-Hackbarth K; Schweigert O; Reiss K; Chalaris A; Scheller J; Rose-John S
FEBS J; 2014 Jan; 281(1):157-74. PubMed ID: 24164679
[TBL] [Abstract][Full Text] [Related]
15. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535
[TBL] [Abstract][Full Text] [Related]
17. Genomic structure and functional characterization of the human ADAM10 promoter.
Prinzen C; Müller U; Endres K; Fahrenholz F; Postina R
FASEB J; 2005 Sep; 19(11):1522-4. PubMed ID: 15972296
[TBL] [Abstract][Full Text] [Related]
18. An ADAM10 promoter polymorphism is a functional variant in severe sepsis patients and confers susceptibility to the development of sepsis.
Cui L; Gao Y; Xie Y; Wang Y; Cai Y; Shao X; Ma X; Li Y; Ma G; Liu G; Cheng W; Liu Y; Liu T; Pan Q; Tao H; Liu Z; Zhao B; Shao Y; Li K
Crit Care; 2015 Mar; 19(1):73. PubMed ID: 25888255
[TBL] [Abstract][Full Text] [Related]
19. [An efficient method for screening effective siRNAs using dual-luciferase reporter assay system].
Shan ZX; Lin QX; Tan HH; Deng CY; Liu XY; Xiao DZ; Yu XY
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1577-81. PubMed ID: 19726297
[TBL] [Abstract][Full Text] [Related]
20. Effects of ADAM10 deletion on Notch-1 signaling pathway and neuronal maintenance in adult mouse brain.
Zhuang J; Wei Q; Lin Z; Zhou C
Gene; 2015 Jan; 555(2):150-8. PubMed ID: 25445276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
